Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -14.41 Million USD | -7.18% |
| 2022 | -13.45 Million USD | -15.04% |
| 2021 | -11.69 Million USD | -21.68% |
| 2020 | -9.6 Million USD | -11.78% |
| 2019 | -8.59 Million USD | 7.76% |
| 2018 | -9.31 Million USD | -0.39% |
| 2017 | -9.28 Million USD | 9.42% |
| 2016 | -10.24 Million USD | 56.84% |
| 2015 | -23.74 Million USD | 11.5% |
| 2014 | -26.82 Million USD | 12.04% |
| 2013 | -30.5 Million USD | -946.57% |
| 2012 | 3.6 Million USD | 109.27% |
| 2011 | -38.86 Million USD | 0.2% |
| 2010 | -38.93 Million USD | -0.54% |
| 2009 | -38.72 Million USD | 0.42% |
| 2008 | -38.89 Million USD | -15.01% |
| 2007 | -33.81 Million USD | -92.97% |
| 2006 | -17.52 Million USD | -149.46% |
| 2005 | -7.02 Million USD | -40.49% |
| 2004 | -5 Million USD | -309.81% |
| 2003 | 2.38 Million USD | 147.06% |
| 2002 | -5.06 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.2 Million USD | -31.27% |
| 2024 Q1 | -2.44 Million USD | 24.85% |
| 2023 FY | -14.41 Million USD | -7.18% |
| 2023 Q2 | -3.66 Million USD | 3.5% |
| 2023 Q4 | -3.24 Million USD | 12.31% |
| 2023 Q1 | -3.8 Million USD | -18.6% |
| 2023 Q3 | -3.7 Million USD | -0.98% |
| 2022 Q2 | -3.43 Million USD | -3.46% |
| 2022 FY | -13.45 Million USD | -15.04% |
| 2022 Q3 | -3.49 Million USD | -1.57% |
| 2022 Q4 | -3.2 Million USD | 8.19% |
| 2022 Q1 | -3.32 Million USD | -11.89% |
| 2021 FY | -11.69 Million USD | -21.68% |
| 2021 Q2 | -3.08 Million USD | -20.73% |
| 2021 Q1 | -2.55 Million USD | 2.22% |
| 2021 Q3 | -3.09 Million USD | -0.32% |
| 2021 Q4 | -2.96 Million USD | 3.98% |
| 2020 FY | -9.6 Million USD | -11.78% |
| 2020 Q1 | -2.66 Million USD | -10.48% |
| 2020 Q2 | -2.13 Million USD | 19.9% |
| 2020 Q3 | -2.19 Million USD | -2.67% |
| 2020 Q4 | -2.61 Million USD | -18.96% |
| 2019 FY | -8.59 Million USD | 7.76% |
| 2019 Q1 | -2.28 Million USD | -21.16% |
| 2019 Q2 | -1.89 Million USD | 16.94% |
| 2019 Q3 | -1.99 Million USD | -5.27% |
| 2019 Q4 | -2.41 Million USD | -20.87% |
| 2018 FY | -9.31 Million USD | -0.39% |
| 2018 Q3 | -2.73 Million USD | -13.1% |
| 2018 Q4 | -1.88 Million USD | 31.09% |
| 2018 Q1 | -2.3 Million USD | 8.78% |
| 2018 Q2 | -2.42 Million USD | -4.9% |
| 2017 Q4 | -2.52 Million USD | -27.6% |
| 2017 FY | -9.28 Million USD | 9.42% |
| 2017 Q3 | -1.98 Million USD | 26.89% |
| 2017 Q2 | -2.71 Million USD | -31.54% |
| 2017 Q1 | -2.06 Million USD | -29.38% |
| 2016 FY | -10.24 Million USD | 56.84% |
| 2016 Q4 | -1.59 Million USD | 39.36% |
| 2016 Q3 | -2.62 Million USD | 18.67% |
| 2016 Q2 | -3.23 Million USD | 50.32% |
| 2016 Q1 | -6.5 Million USD | -10.15% |
| 2015 Q1 | -5.83 Million USD | 0.38% |
| 2015 Q4 | -5.9 Million USD | -0.34% |
| 2015 Q3 | -5.88 Million USD | 4.03% |
| 2015 Q2 | -6.12 Million USD | -5.13% |
| 2015 FY | -23.74 Million USD | 11.5% |
| 2014 Q4 | -5.85 Million USD | 12.84% |
| 2014 FY | -26.82 Million USD | 12.04% |
| 2014 Q1 | -8.16 Million USD | 5.34% |
| 2014 Q2 | -7.23 Million USD | 11.29% |
| 2014 Q3 | -6.71 Million USD | 7.25% |
| 2013 Q1 | -6.78 Million USD | 28.73% |
| 2013 Q2 | -7.85 Million USD | -15.8% |
| 2013 FY | -30.5 Million USD | -946.57% |
| 2013 Q3 | -7.24 Million USD | 7.83% |
| 2013 Q4 | -8.62 Million USD | -19.03% |
| 2012 Q2 | -7.95 Million USD | -127.61% |
| 2012 FY | 3.6 Million USD | 109.27% |
| 2012 Q4 | -9.52 Million USD | -22.95% |
| 2012 Q3 | -7.74 Million USD | 2.69% |
| 2012 Q1 | 28.82 Million USD | 399.71% |
| 2011 Q2 | -10 Million USD | -3.57% |
| 2011 Q1 | -9.66 Million USD | -1.86% |
| 2011 Q3 | -9.57 Million USD | 4.26% |
| 2011 Q4 | -9.61 Million USD | -0.4% |
| 2011 FY | -38.86 Million USD | 0.2% |
| 2010 FY | -38.93 Million USD | -0.54% |
| 2010 Q3 | -10.02 Million USD | -4.64% |
| 2010 Q1 | -9.85 Million USD | -0.33% |
| 2010 Q2 | -9.57 Million USD | 2.84% |
| 2010 Q4 | -9.48 Million USD | 5.36% |
| 2009 FY | -38.72 Million USD | 0.42% |
| 2009 Q4 | -9.82 Million USD | -3.1% |
| 2009 Q1 | -9.46 Million USD | -1.27% |
| 2009 Q2 | -9.91 Million USD | -4.78% |
| 2009 Q3 | -9.53 Million USD | 3.86% |
| 2008 Q3 | -10.26 Million USD | -6.35% |
| 2008 Q4 | -9.34 Million USD | 9.02% |
| 2008 Q2 | -9.65 Million USD | -0.29% |
| 2008 Q1 | -9.62 Million USD | -11.72% |
| 2008 FY | -38.89 Million USD | -15.01% |
| 2007 FY | -33.81 Million USD | -92.97% |
| 2007 Q3 | -9.78 Million USD | -6.44% |
| 2007 Q2 | -9.19 Million USD | -47.61% |
| 2007 Q1 | -6.22 Million USD | 25.87% |
| 2007 Q4 | -8.61 Million USD | 11.91% |
| 2006 Q1 | -431.71 Thousand USD | 95.29% |
| 2006 Q2 | -2.33 Million USD | -441.43% |
| 2006 Q3 | -4.45 Million USD | -90.38% |
| 2006 Q4 | -8.39 Million USD | -88.74% |
| 2006 FY | -17.52 Million USD | -149.46% |
| 2005 Q2 | 807.46 Thousand USD | 15.12% |
| 2005 Q1 | 701.41 Thousand USD | 109.04% |
| 2005 FY | -7.02 Million USD | -40.49% |
| 2005 Q4 | -9.16 Million USD | -1541.63% |
| 2005 Q3 | 636.05 Thousand USD | -21.23% |
| 2004 Q1 | 919.55 Thousand USD | 0.0% |
| 2004 FY | -5 Million USD | -309.81% |
| 2004 Q2 | 919.55 Thousand USD | 0.0% |
| 2004 Q4 | -7.75 Million USD | -943.77% |
| 2004 Q3 | 919.55 Thousand USD | 0.0% |
| 2003 FY | 2.38 Million USD | 147.06% |
| 2002 FY | -5.06 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 44.82 Million USD | 132.166% |
| Muliang Viagoo Technology, Inc. | 467.3 Thousand USD | 3185.164% |
| N2OFF, Inc. | -7.57 Million USD | -90.254% |
| Arcadia Biosciences, Inc. | -13.93 Million USD | -3.437% |